Frontiers in nephrology最新文献

筛选
英文 中文
Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors. 肾脏病临床中患有慢性肾病的八十多岁老人:进展者与非进展者
Frontiers in nephrology Pub Date : 2023-02-01 eCollection Date: 2023-01-01 DOI: 10.3389/fneph.2023.1114486
Aida Frías, Francisco Vargas, Justo Sandino, Raquel Berzal, Marta Rivero, Lucía Cordero, Teresa Cavero, Julián Segura, Florencio García, Eduardo Hernández, Eduardo Gutiérrez, Pilar Auñón, Irene Zamanillo, Julio Pascual, Enrique Morales
{"title":"Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors.","authors":"Aida Frías,&nbsp;Francisco Vargas,&nbsp;Justo Sandino,&nbsp;Raquel Berzal,&nbsp;Marta Rivero,&nbsp;Lucía Cordero,&nbsp;Teresa Cavero,&nbsp;Julián Segura,&nbsp;Florencio García,&nbsp;Eduardo Hernández,&nbsp;Eduardo Gutiérrez,&nbsp;Pilar Auñón,&nbsp;Irene Zamanillo,&nbsp;Julio Pascual,&nbsp;Enrique Morales","doi":"10.3389/fneph.2023.1114486","DOIUrl":"10.3389/fneph.2023.1114486","url":null,"abstract":"<p><strong>Background: </strong>The current definition of chronic kidney disease applied to patients over the age of 80 has increased the number of referrals to Nephrology. However not all of these patients may benefit from its assessment. This study aims to analyze the evolution of ≥80 years old patients referred to Nephrology.</p><p><strong>Methods: </strong>Single-center study including patients ≥80 years old with eGFR <60 mL/min/1,73m2 who were referred to Nephrology consultation for the first time. Clinical and analytical parameters were collected retrospectively 12 months before the visit, and prospectively at baseline, and 12 and 24 months after the initial visit. We divided patients into two groups based on annual eGFR loss: progressors (>5 mL/min/1.73m2) and non-progressors (≤5 mL/min/1,73m2).</p><p><strong>Results: </strong>A total of 318 patients were included, mean age was 84,9 ± 4 (80-97) years. Baseline serum creatinine was 1,65 ± 0,62 mg/dL, eGRF 35 (28-42) mL/min/1,73, and albumin/creatinine ratio 36 (7-229) mg/g. 55,7% of the patients met the definition of progressor at baseline (initial-progressors), 26,3% were progressors after a 12-month follow-up and 13,4% after 24 months. 21,2% and 11,4% of initial-progressors met this definition at 12 and 24 month follow up. The main risk factor for progression was albuminuria. No relationship was found between the nephrologist intervention and the evolution of renal function among initial non-progressors.</p><p><strong>Conclusion: </strong>Elderly patients who have stable renal function at the time of referral will continue to have stable renal function over the subsequent 24 months and thus may not need to be referred to a nephrologist.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"3 ","pages":"1114486"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10171637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal blood purification in patients with liver failure: Considerations for the low-and-middle income countries of Latin America. 肝功能衰竭患者的体外血液净化:拉丁美洲中低收入国家的考虑因素。
Frontiers in nephrology Pub Date : 2023-01-31 eCollection Date: 2023-01-01 DOI: 10.3389/fneph.2023.938710
Vladimir Barrera Villanueva, Daniel Alejandro Barrera Amorós, Eira Ingrid Castillo Echeverria, Luis F Budar-Fernández, Omar Israel Salas Nolasco, Luis A Juncos, Lilia Rizo-Topete
{"title":"Extracorporeal blood purification in patients with liver failure: Considerations for the low-and-middle income countries of Latin America.","authors":"Vladimir Barrera Villanueva, Daniel Alejandro Barrera Amorós, Eira Ingrid Castillo Echeverria, Luis F Budar-Fernández, Omar Israel Salas Nolasco, Luis A Juncos, Lilia Rizo-Topete","doi":"10.3389/fneph.2023.938710","DOIUrl":"10.3389/fneph.2023.938710","url":null,"abstract":"<p><p>Severe liver failure is common in Low-and-Medium Income Countries (LMIC) and is associated with a high morbidity, mortality and represents an important burden to the healthcare system. In its most severe state, liver failure is a medical emergency, that requires supportive care until either the liver recovers or a liver transplant is performed. Frequently the patient requires intensive support until their liver recovers or they receive a liver transplant. Extracorporeal blood purification techniques can be employed as a strategy for bridging to transplantation or recovery. The most common type of extracorporeal support provided to these patients is kidney replacement therapy (KRT), as acute kidney injury is very common in these patients and KRT devices more readily available. However, because most of the substances that the liver clears are lipophilic and albumin-bound, they are not cleared effectively by KRT. Hence, there has been much effort in developing devices that more closely resemble the clearance function of the liver. This article provides a review of various non-biologic extracorporeal liver support devices that can be used to support these patients, and our perspective keeping in mind the needs and unique challenges present in the LMIC of Latin America.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"3 ","pages":"938710"},"PeriodicalIF":0.0,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10551194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential of mHealth for older adults on dialysis and their care partners: What's been done and where do we go from here? mHealth对接受透析的老年人及其护理伙伴的潜力:已经做了什么,我们将何去何从?
Frontiers in nephrology Pub Date : 2023-01-06 eCollection Date: 2022-01-01 DOI: 10.3389/fneph.2022.1068395
Brett Burrows, Nicole DePasquale, Jessica Ma, C Barrett Bowling
{"title":"The potential of mHealth for older adults on dialysis and their care partners: What's been done and where do we go from here?","authors":"Brett Burrows, Nicole DePasquale, Jessica Ma, C Barrett Bowling","doi":"10.3389/fneph.2022.1068395","DOIUrl":"10.3389/fneph.2022.1068395","url":null,"abstract":"<p><p>Self-care, or the dynamic, daily process of becoming actively involved in one's own care, is paramount to prevent and manage complications of end-stage kidney disease. However, many older dialysis patients face distinctive challenges to adequate engagement in self-care. One promising strategy for facilitating self-care among older dialysis patients and their care partners is the utilization of mobile health (mhealth). mHealth encompasses mobile and wireless communication devices used to improve healthcare delivery, patient and care partner outcomes, and patient care. In other disease populations, mHealth has been linked to maintenance of or improvements in self-management, medication compliance, patient education, and patient-provider communication, all of which can slow disease progression. Although mHealth is considered feasible, acceptable, and clinically useful, this technology has predominately targeted younger patients. Thus, there is a need to develop mHealth for older dialysis patients and their care partners. In this article, we describe current mHealth usage in older dialysis patients, including promising findings, challenges, and research gaps. Given the lack of research on mHealth among care partners of older dialysis patients, we highlight lessons learned from other disease populations to inform the future design and implementation of mHealth for these key stakeholders. We also propose that leveraging care partners represents an opportunity to meaningfully tailor mHealth applications and, by extension, improve care partner physical and mental health and decrease caregiver burden. We conclude with a summary of future directions to help older dialysis patients and their care partners receive recognition as target end-users amid the constant evolution of mHealth.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"2 ","pages":"1068395"},"PeriodicalIF":0.0,"publicationDate":"2023-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10183337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical activity is a potential measure of physical resilience in older adults receiving hemodialysis. 体育活动是衡量接受血液透析的老年人身体恢复能力的潜在指标。
Frontiers in nephrology Pub Date : 2023-01-06 eCollection Date: 2022-01-01 DOI: 10.3389/fneph.2022.1032468
Anika Lucas, Jeanette Rutledge, Richard Sloane, Katherine Hall, Ciara Green, Carl Pieper, Cathleen Colón-Emeric, Rasheeda Hall
{"title":"Physical activity is a potential measure of physical resilience in older adults receiving hemodialysis.","authors":"Anika Lucas, Jeanette Rutledge, Richard Sloane, Katherine Hall, Ciara Green, Carl Pieper, Cathleen Colón-Emeric, Rasheeda Hall","doi":"10.3389/fneph.2022.1032468","DOIUrl":"10.3389/fneph.2022.1032468","url":null,"abstract":"<p><strong>Background: </strong>Physical resilience, or the ability to recover after a physical stressor, declines with aging. Efforts to preserve physical resilience in the older dialysis population are critically needed; however, validated, patient-centered measures that are sensitive to change are also needed. Our objective was to assess accelerometer-derived step count variability, or a measure of intra-individual variation in physical activity, as a potential measure of physical resilience among older adults receiving hemodialysis.</p><p><strong>Methods: </strong>Community-dwelling ambulatory older adults receiving in-center hemodialysis were prospectively enrolled. Participants wore wrist accelerometers during daytime hours on both dialysis and non-dialysis days up to 14 days, and the feasibility of accelerometer use was assessed from wear time. We used accelerometer data to compute step counts in 4-hour blocks and step count variability. Physical function was assessed with the Short Physical Performance Battery (SPPB which includes gait speed test), grip strength, activities of daily living (ADLs) instruments, and life space mobility. We assessed interval fatigue (subjective rating from 0 to 10) on dialysis and non-dialysis days and self-reported recovery time. We assessed the correlations of step count variability with measures of physical function and step count and interval fatigue.</p><p><strong>Results: </strong>Of 37 enrolled participants, 29 had sufficient accelerometer data for analyses. Among the 29 participants, mean (SD) age was 70.6(4.8) years, and 55% (n=16) were male and 72% (n=21) were Black race. Participants were largely sedentary with median (Q1-Q3) self-reported total kilocalories per week of 200 (36-552). Step count variability was positively correlated with measures of physical function: SPPB (r=0.50, p<0.05), gait speed (r=0.59, p<0.05), handgrip strength (r=0.71, p<0.05), Instrumental ADLs (r=0.44, p<0.05) and life space mobility (r=0.54, p<0.05).There was a weak inverse correlation between post-dialysis step counts (4-hour blocks after a dialysis session) and post-dialysis interval fatigue [r=-0.19 (n=102, p=0.06).</p><p><strong>Conclusions: </strong>Physical activity assessment <i>via</i> accelerometer is feasible for older adults receiving hemodialysis. Step count variability correlated with physical function, so it may be a novel measure of physical resilience. Further studies are needed to validate this measure.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"2 ","pages":"1032468"},"PeriodicalIF":0.0,"publicationDate":"2023-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10179939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients 更正:Cemiplimab治疗肾移植受者的晚期皮肤鳞状细胞癌
Frontiers in nephrology Pub Date : 2023-01-05 DOI: 10.3389/fneph.2022.1129134
T. Van Meerhaeghe, J. Baurain, O. Bechter, C. Orte Cano, V. del Marmol, A. Devresse, P. Doubel, M. Hanssens, R. Hellemans, D. Liénard, A. Rutten, B. Sprangers, A. Le Moine, S. Aspeslagh
{"title":"Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients","authors":"T. Van Meerhaeghe, J. Baurain, O. Bechter, C. Orte Cano, V. del Marmol, A. Devresse, P. Doubel, M. Hanssens, R. Hellemans, D. Liénard, A. Rutten, B. Sprangers, A. Le Moine, S. Aspeslagh","doi":"10.3389/fneph.2022.1129134","DOIUrl":"https://doi.org/10.3389/fneph.2022.1129134","url":null,"abstract":"COPYRIGHT © 2023 Van Meerhaeghe, Baurain, Bechter, Orte Cano, Del Marmol, Devresse, Doubel, Hanssens, Hellemans, Lienard, Rutten, Sprangers, Le Moine and Aspeslagh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Correction PUBLISHED 05 January 2023 DOI 10.3389/fneph.2022.1129134","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43297914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Critical care nephrology: a multiorgan subspecialty in the ICU. 社论:重症肾病学:ICU的一个多器官亚专科。
Frontiers in nephrology Pub Date : 2023-01-01 DOI: 10.3389/fneph.2023.1269846
Rolando Claure-Del Granado, Javier A Neyra
{"title":"Editorial: Critical care nephrology: a multiorgan subspecialty in the ICU.","authors":"Rolando Claure-Del Granado,&nbsp;Javier A Neyra","doi":"10.3389/fneph.2023.1269846","DOIUrl":"https://doi.org/10.3389/fneph.2023.1269846","url":null,"abstract":"COPYRIGHT © 2023 Claure-Del Granado and Neyra. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Editorial PUBLISHED 18 August 2023 DOI 10.3389/fneph.2023.1269846","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"3 ","pages":"1269846"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10171636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The roles of heme oxygenase-1 in renal disease. 血红素加氧酶-1在肾脏疾病中的作用。
Frontiers in nephrology Pub Date : 2023-01-01 DOI: 10.3389/fneph.2023.1156346
Hongfu Zhai, Lihua Ni, Xiaoyan Wu
{"title":"The roles of heme oxygenase-1 in renal disease.","authors":"Hongfu Zhai,&nbsp;Lihua Ni,&nbsp;Xiaoyan Wu","doi":"10.3389/fneph.2023.1156346","DOIUrl":"https://doi.org/10.3389/fneph.2023.1156346","url":null,"abstract":"<p><p>Heme oxygenase (HO), a heat shock protein containing hemoglobin, is an important enzyme in heme catabolism. It is involved in cell homeostasis and has anti-inflammatory, antioxidant, anti-apoptosis, immunomodulation, and other functions. It is expressed at a modest level in most normal tissues. When the body suffers from ischemia hypoxia, injury, toxins, and other nociceptive stimuli, the expression increases, which can transform the oxidative microenvironment into an antioxidant environment to promote tissue recovery from damage. In recent years, research has continued to verify its value in a variety of human bodily systems. It is also regarded as a key target for the treatment of numerous disorders. With the advancement of studies, its significance in renal disease has gained increasing attention. It is thought to have a significant protective function in preventing acute kidney injury and delaying the progression of chronic renal diseases. Its protective mechanisms include anti-inflammatory, antioxidant, cell cycle regulation, apoptosis inhibition, hemodynamic regulation, and other aspects, which have been demonstrated in diverse animal models. Furthermore, as a protective factor, its potential therapeutic efficacy in renal disease has recently become a hot area of research. Although a large number of preclinical trials have confirmed its therapeutic potential in reducing kidney injury, due to the problems and side effects of HO-1 induction therapy, its efficacy and safety in clinical application need to be further explored. In this review, we summarize the current state of research on the mechanism, location, and treatment of HO and its relationship with various renal diseases.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"3 ","pages":"1156346"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10237267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of risk factors for severe acute kidney injury in patients with acute myocardial infarction: A retrospective study. 急性心肌梗死患者严重急性肾损伤的危险因素分析:一项回顾性研究。
Frontiers in nephrology Pub Date : 2023-01-01 DOI: 10.3389/fneph.2023.1047249
Yuxin Nong, Xuebiao Wei, Hongrui Qiu, Honghao Yang, Jiale Yang, Junquan Lu, Jianfeng Cao, Yanbin Fu, Danqing Yu
{"title":"Analysis of risk factors for severe acute kidney injury in patients with acute myocardial infarction: A retrospective study.","authors":"Yuxin Nong,&nbsp;Xuebiao Wei,&nbsp;Hongrui Qiu,&nbsp;Honghao Yang,&nbsp;Jiale Yang,&nbsp;Junquan Lu,&nbsp;Jianfeng Cao,&nbsp;Yanbin Fu,&nbsp;Danqing Yu","doi":"10.3389/fneph.2023.1047249","DOIUrl":"https://doi.org/10.3389/fneph.2023.1047249","url":null,"abstract":"<p><strong>Background: </strong>Patients with acute myocardial infarction (AMI) complicated by acute kidney injury (AKI) tend to have a poor prognosis. However, the exact mechanism of the co-occurrence of the two diseases is unknown. Therefore, this study aims to determine the risk factors for severe AKI in patients with AMI.</p><p><strong>Methods: </strong>A total of 2022 patients were included in the Medical Information Mart for Intensive Care. Variables were identified <i>via</i> univariate logistic regression, and the variables were corrected <i>via</i> multivariate logistic regression. Restricted cubic splines were used to examine the risks associated with the variables. The Kaplan-Meier method was used to compare the risk of severe AKI among the patients.</p><p><strong>Results: </strong>Patients with severe AKI had a higher in-hospital mortality rate (28.6% vs. 9.0%, P < 0.001) and a longer duration of intensive care (6.5 days vs. 2.9 days, P < 0.001). In patients with AMI, the mean systolic blood pressure (SBP); international normalized ratio (INR); the levels of blood urea nitrogen (BUN), glucose, and calcium; and a history of liver disease were found to be the independent risk factors for developing severe AKI after their admission. Increased levels of BUN and blood glucose and a high INR increased the risk of severe AKI; however, increased levels of calcium decreased the risk; SBP presented a U-shaped curve relationship.</p><p><strong>Conclusions: </strong>Patients with severe AKI have a poor prognosis following an episode of AMI. Furthermore, in patients with AMI, SBP; INR; a history of liver disease; and the levels of BUN, glucose, and calcium are the independent risk factors for developing severe AKI after their admission.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"3 ","pages":"1047249"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10237272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Editorial: Social determinants of kidney health: a global perspective. 社论:肾脏健康的社会决定因素:全球视角。
Frontiers in nephrology Pub Date : 2023-01-01 DOI: 10.3389/fneph.2023.1260221
Guillermo Garcia-Garcia, Keith C Norris, Manisha Sahay, Ifeoma I Ulasi
{"title":"Editorial: Social determinants of kidney health: a global perspective.","authors":"Guillermo Garcia-Garcia,&nbsp;Keith C Norris,&nbsp;Manisha Sahay,&nbsp;Ifeoma I Ulasi","doi":"10.3389/fneph.2023.1260221","DOIUrl":"https://doi.org/10.3389/fneph.2023.1260221","url":null,"abstract":"COPYRIGHT © 2023 Garcia-Garcia, Norris, Sahay and Ulasi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Editorial PUBLISHED 14 August 2023 DOI 10.3389/fneph.2023.1260221","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"3 ","pages":"1260221"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10172986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Immune checkpoint inhibitor-induced multiorgan vasculitis successfully treated with rituximab. 病例报告:利妥昔单抗成功治疗免疫检查点抑制剂诱导的多器官血管炎。
Frontiers in nephrology Pub Date : 2023-01-01 DOI: 10.3389/fneph.2023.1168614
Sehrish Qureshi, Naszrin Arani, Vishnu Parvathareddy, Amanda Tchakarov, Maen Abdelrahim, Maria Suarez-Almazor, Jianjun Zhang, Don Lynn Gibbons, John Heymach, Mehmet Altan, Ala Abudayyeh
{"title":"Case Report: Immune checkpoint inhibitor-induced multiorgan vasculitis successfully treated with rituximab.","authors":"Sehrish Qureshi,&nbsp;Naszrin Arani,&nbsp;Vishnu Parvathareddy,&nbsp;Amanda Tchakarov,&nbsp;Maen Abdelrahim,&nbsp;Maria Suarez-Almazor,&nbsp;Jianjun Zhang,&nbsp;Don Lynn Gibbons,&nbsp;John Heymach,&nbsp;Mehmet Altan,&nbsp;Ala Abudayyeh","doi":"10.3389/fneph.2023.1168614","DOIUrl":"https://doi.org/10.3389/fneph.2023.1168614","url":null,"abstract":"<p><p>Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer. ICIs have a unique side effect profile, generally caused by inflammatory tissue damage, with clinical features similar to autoimmune conditions. Acute kidney injury from ICIs has been well studied; incidence ranges from 1% to 5%, with higher incidence when combination ICI therapies are used. Although the overall reported incidence of ICI-associated glomerulonephritis is less than 1%, vasculitis is the most commonly reported ICI-related glomerulonephritis. Other biopsy findings include thrombotic microangiopathy, focal segmental glomerulosclerosis, minimal change disease, and IgA nephropathy with secondary amyloidosis. We report a case in which a woman previously treated with the PD-L1 inhibitor durvalumab for locally advanced non-small cell lung cancer with pre-existing antineutrophil cytoplasmic (anti-PR3) antibody who later developed multi-organ vasculitis after ICI exposure, which was successfully treated with rituximab, with continued cancer remission for 3 years.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"3 ","pages":"1168614"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479603/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10237266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信